Skip to main content
Log in

Detection and staging of chronic obstructive pulmonary disease using a computed tomography–based weakly supervised deep learning approach

  • Chest
  • Published:
European Radiology Aims and scope Submit manuscript

A Correction to this article was published on 23 March 2022

This article has been updated

Abstract

Objectives

Chronic obstructive pulmonary disease (COPD) is underdiagnosed globally. The present study aimed to develop weakly supervised deep learning (DL) models that utilize computed tomography (CT) image data for the automated detection and staging of spirometry-defined COPD.

Methods

A large, highly heterogeneous dataset was established, consisting of 1393 participants retrospectively recruited from outpatient, inpatient, and physical examination center settings of four large public hospitals in China. All participants underwent both inspiratory chest CT scans and pulmonary function tests. CT images, spirometry data, demographic information, and clinical information of each participant were collected. An attention-based multi-instance learning (MIL) model for COPD detection was trained using CT scans from 837 participants. External validation of the COPD detection was performed with 620 low-dose CT (LDCT) scans acquired from the National Lung Screening Trial (NLST) cohort. A multi-channel 3D residual network was further developed to categorize GOLD stages among confirmed COPD patients.

Results

The attention-based MIL model used for COPD detection achieved an area under the receiver operating characteristic curve (AUC) of 0.934 (95% CI: 0.903, 0.961) on the internal test set and 0.866 (95% CI: 0.805, 0.928) on the LDCT subset acquired from the NLST. The multi-channel 3D residual network was able to correctly grade 76.4% of COPD patients in the test set (423/553) using the GOLD scale.

Conclusions

The proposed chest CT-DL approach can automatically identify spirometry-defined COPD and categorize patients according to the GOLD scale. As such, this approach may be an effective case-finding tool for COPD diagnosis and staging.

Key Points

Chronic obstructive pulmonary disease is underdiagnosed globally, particularly in developing countries.

The proposed chest computed tomography (CT)–based deep learning (DL) approaches could accurately identify spirometry-defined COPD and categorize patients according to the GOLD scale.

The chest CT-DL approach may be an alternative case-finding tool for COPD identification and evaluation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Change history

Abbreviations

%LAA-950:

The percentage of lung volume less than or equal to −950 Hounsfield units

95% CI:

95% confidence interval

AI:

Artificial intelligence

AUC:

Area under the receiver operating characteristic curve

BMI:

Body mass index

COPD:

Chronic obstructive pulmonary disease

CT:

Computed tomography

DL:

Deep learning

FEV1:

Forced expiratory volume in 1 second

FVC:

Forced vital capacity

IQR:

Interquartile range

LDCT:

Low-dose computed tomography

MIL:

Multi-instance learning

NA:

Not applicable

NLST:

National Lung Screening Trial

NPV:

Negative predictive value

PPV:

Positive predictive value

SD:

Standard deviation

Yrs:

Years

References

  1. Disease GBD, Injury I, Prevalence C (2016) Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388:1545–1602

    Article  Google Scholar 

  2. Halpin DMG, Criner GJ, Papi A et al (2021) Global initiative for the diagnosis, management, and prevention of chronic obstructive lung disease. The 2020 GOLD Science Committee report on COVID-19 and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 203:24–36

    Article  CAS  Google Scholar 

  3. Jithoo A, Enright PL, Burney P et al (2013) Case-finding options for COPD: results from the Burden of Obstructive Lung Disease study. Eur Respir J 41:548–555

    Article  Google Scholar 

  4. Perez-Padilla R, Thirion-Romero I, Guzman N (2018) Underdiagnosis of chronic obstructive pulmonary disease: should smokers be offered routine spirometry tests? Expert Rev Respir Med 12:83–85

    Article  CAS  Google Scholar 

  5. Lamprecht B, Soriano JB, Studnicka M et al (2015) Determinants of underdiagnosis of COPD in national and international surveys. Chest 148:971–985

    Article  Google Scholar 

  6. Wang C, Xu J, Yang L et al (2018) Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet 391:1706–1717

    Article  Google Scholar 

  7. Miller MR, Levy ML (2015) Chronic obstructive pulmonary disease: missed diagnosis versus misdiagnosis. BMJ 351:h3021

    Article  Google Scholar 

  8. Estepar RS, Kinney GL, Black-Shinn JL et al (2013) Computed tomographic measures of pulmonary vascular morphology in smokers and their clinical implications. Am J Respir Crit Care Med 188:231–239

    Article  Google Scholar 

  9. McDonald ML, Diaz AA, Ross JC et al (2014) Quantitative computed tomography measures of pectoralis muscle area and disease severity in chronic obstructive pulmonary disease. A cross-sectional study. Ann Am Thorac Soc 11:326–334

    Article  Google Scholar 

  10. Bhatt SP, Washko GR, Hoffman EA et al (2019) Imaging advances in chronic obstructive pulmonary disease. Insights from the Genetic Epidemiology of Chronic Obstructive Pulmonary Disease (COPDGene) study. Am J Respir Crit Care Med 199:286–301

    Article  Google Scholar 

  11. Park J, Hobbs BD, Crapo JD et al (2019) Subtyping COPD using visual and quantitative CT features. Chest. https://doi.org/10.1016/j.chest.2019.06.015

  12. Washko GR, Parraga G (2018) COPD biomarkers and phenotypes: opportunities for better outcomes with precision imaging. Eur Respir J 52

  13. Kauczor HU, Bonomo L, Gaga M et al (2015) ESR/ERS white paper on lung cancer screening. Eur Radiol 25:2519–2531

    Article  Google Scholar 

  14. Lathan C, Frank DA (2013) ACP Journal Club. Review: Low-dose CT screening reduces lung cancer and mortality in current or former smokers. Ann Intern Med 159(JC3)

  15. Chassagnon G, Vakalopolou M, Paragios N, Revel MP (2020) Deep learning: definition and perspectives for thoracic imaging. Eur Radiol 30:2021–2030

    Article  Google Scholar 

  16. Philbrick KA, Yoshida K, Inoue D et al (2018) What does deep learning see? Insights from a classifier trained to predict contrast enhancement phase from CT images. AJR Am J Roentgenol 211:1184–1193

    Article  Google Scholar 

  17. Kermany DS, Goldbaum M, Cai W et al (2018) Identifying medical diagnoses and treatable diseases by image-based deep learning. Cell 172:1122–1131 e1129

    Article  CAS  Google Scholar 

  18. Cho YH, Lee SM, Seo JB et al (2018) Quantitative assessment of pulmonary vascular alterations in chronic obstructive lung disease: associations with pulmonary function test and survival in the KOLD cohort. Eur J Radiol 108:276–282

    Article  Google Scholar 

  19. Lynch DA, Moore CM, Wilson C et al (2018) CT-based visual classification of emphysema: association with mortality in the COPDGene study. Radiology 288:859–866

    Article  Google Scholar 

  20. Peng L, Lin L, Hu H et al (2019) Classification and quantification of emphysema using a multi-scale residual network. IEEE J Biomed Health Inform 23:2526–2536

    Article  Google Scholar 

  21. Nambu A, Zach J, Schroeder J et al (2016) Quantitative computed tomography measurements to evaluate airway disease in chronic obstructive pulmonary disease: relationship to physiological measurements, clinical index and visual assessment of airway disease. Eur J Radiol 85:2144–2151

    Article  Google Scholar 

  22. Gonzalez G, Ash SY, Vegas-Sanchez-Ferrero G et al (2018) Disease staging and prognosis in smokers using deep learning in chest computed tomography. Am J Respir Crit Care Med 197:193–203

    Article  Google Scholar 

  23. Hatt CR, Galban CJ, Labaki W, Kazerooni EA, Han ML (2018) Convolutional neural network based COPD and emphysema classifications are predictive of lung cancer diagnosis. Image Analysis for Moving Organ, Breast, and Thoracic Images:11040

  24. Tang LYW, Coxson HO, Lam S, Leipsic J, Tam RC, Sin DD (2020) Towards large-scale case-finding: training and validation of residual networks for detection of chronic obstructive pulmonary disease using low-dose CT. Lancet Digit Health 2:e259–e267

    Article  Google Scholar 

  25. National Lung Screening Trial Research T, Aberle DR, Adams AM et al (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365:395–409

    Article  Google Scholar 

  26. Xu C, Qi S, Feng J et al (2020) DCT-MIL: deep CNN transferred multiple instance learning for COPD identification using CT images. Phys Med Biol 65:145011

    Article  Google Scholar 

  27. Yan X, Tao M, Feng Q, Zhong P, Chang IC (2014) Deep learning of feature representation with multiple instance learning for medical image analysis. IEEE International Conference on Acoustics,

  28. Shen Y, Wu N, Phang J et al (2021) An interpretable classifier for high-resolution breast cancer screening images utilizing weakly supervised localization. Med Image Anal 68:101908

    Article  Google Scholar 

  29. Ilse M, Tomczak JM, Welling M (2018) Attention-based deep multiple instance learning. The 35th International Conference on Machine Learning,

  30. Alom MZ, Yakopcic C, Hasan M, Taha TM, Asari VK (2019) Recurrent residual U-Net for medical image segmentation. J Med Imaging (Bellingham) 6:014006

    Google Scholar 

  31. Fluss R, Faraggi D, Reiser B (2005) Estimation of the Youden Index and its associated cutoff point. Biom J 47:458–472

    Article  Google Scholar 

  32. Young KA, Strand M, Ragland MF et al (2019) Pulmonary subtypes exhibit differential global initiative for chronic obstructive lung disease spirometry stage progression: the COPDGene(R) study. Chronic Obstr Pulm Dis 6:414–429

    PubMed  PubMed Central  Google Scholar 

  33. Kinney GL, Santorico SA, Young KA et al (2018) Identification of chronic obstructive pulmonary disease axes that predict all-cause mortality: the COPDGene study. Am J Epidemiol 187:2109–2116

    Article  Google Scholar 

  34. Woodruff PG, Barr RG, Bleecker E et al (2016) Clinical significance of symptoms in smokers with preserved pulmonary function. N Engl J Med 374:1811–1821

    Article  CAS  Google Scholar 

  35. Lowe KE, Regan EA, Anzueto A et al (2019) COPDGene((R)) 2019: redefining the diagnosis of chronic obstructive pulmonary disease. Chronic Obstr Pulm Dis 6:384–399

    PubMed  PubMed Central  Google Scholar 

  36. Esteva A, Robicquet A, Ramsundar B et al (2019) A guide to deep learning in healthcare. Nat Med 25:24–29

    Article  CAS  Google Scholar 

  37. Pino Pena I, Cheplygina V, Paschaloudi S et al (2018) Automatic emphysema detection using weakly labeled HRCT lung images. PLoS One 13:e0205397

    Article  Google Scholar 

Download references

Acknowledgements

We thank LetPub (www.letpub.com) for linguistic assistance and pre-submission expert review.

Funding

This work was supported by the National Key R&D Program (2018YFC1313700), the National Natural Science Foundation of China (grant nos. 82100089, 81870064, and 82070086), and the “Gaoyuan” project of Pudong Health and Family Planning Commission (PWYgy2018-06).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Kun Wang or Qiang Li.

Ethics declarations

Guarantor

The scientific guarantor of this publication is professor Qiang Li, the head of the Department of Pulmonary and Critical Care Medicine of Shanghai East Hospital, Tongji University School of Medicine.

Conflict of interest

The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.

Informed consent

The requirement for written informed consent was waived due to the retrospective nature of the study.

Ethical approval

This study was approved by the ethics commissions of all participating hospitals, including the Affiliated Hospital of Qingdao University, Changsha First Hospital, People’s Liberation Army Joint Logistic Support Force 920th Hospital, and Shandong Provincial Hospital.

Methodology

• retrospective

• diagnostic or prognostic study

• multi-center study

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The original online version of this article was revised: in this article only the authors Jiaxing Sun and Yusheng Yan were initially listed as having equally contributed to this work. This has been corrected to include the author Ximing Liao, as all three have contributed equally to the data collection, analyzing and drafting of the manuscript.

Supplementary Information

ESM 1

(DOCX 5694 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sun, J., Liao, X., Yan, Y. et al. Detection and staging of chronic obstructive pulmonary disease using a computed tomography–based weakly supervised deep learning approach. Eur Radiol 32, 5319–5329 (2022). https://doi.org/10.1007/s00330-022-08632-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-022-08632-7

Keywords

Navigation